Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Other Non-Current Assets (2019 - 2025)

Harmony Biosciences Holdings' Other Non-Current Assets history spans 7 years, with the latest figure at $270000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Assets changed 0.0% year-over-year to $270000.0; the TTM value through Dec 2025 reached $270000.0, changed 0.0%, while the annual FY2025 figure was $270000.0, 0.0% changed from the prior year.
  • Other Non-Current Assets for Q4 2025 was $270000.0 at Harmony Biosciences Holdings, down from $9.7 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $9.7 million in Q3 2025 and bottomed at $152000.0 in Q1 2021.
  • The 5-year median for Other Non-Current Assets is $750000.0 (2021), against an average of $1.8 million.
  • The largest annual shift saw Other Non-Current Assets skyrocketed 2486.0% in 2024 before it tumbled 95.82% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $750000.0 in 2021, then changed by 0.0% to $750000.0 in 2022, then tumbled by 64.0% to $270000.0 in 2023, then changed by 0.0% to $270000.0 in 2024, then changed by 0.0% to $270000.0 in 2025.
  • Per Business Quant, the three most recent readings for HRMY's Other Non-Current Assets are $270000.0 (Q4 2025), $9.7 million (Q3 2025), and $270000.0 (Q2 2025).